STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS OF ZIDOVUDINE AND LAMIVUDINE FROM THEIR COMBINATION DRUG PRODUCT
DOI:
https://doi.org/10.61280/tjpls.v8i1.52Keywords:
Zidovudine, Lamivudine, HIV, RP-HPLC methodAbstract
A simple and precise chromatographic stability indicating reverse phased HPLC method for estimation zidovudine (ZDV) and lamivudine (LMV) from their combination product has been developed and validated using different validation parameters. In the developed RP HPLC method, YMC, Pack ODS A, (250 mm X 4.6 mm), 5 μm column is used. The mobile phase consisting of Acetate Buffer pH 4.0 and methanol in the proportion of 80:20 (v/v). The detection was done using photodiode array detector at 270 nm. The combination drug product of ZDV and LMV was exposed to thermal, photolytic, hydrolytic, and oxidative stress conditions, and the stressed samples were analysed by the designed method. The data of peak homogeneity in stressed sample chromatograms of ZDV and LMV peaks, illustrated the specificity of the method for their estimation in presence of degradants. The described method was linear over a range of 0.025 ppm to 0.75 ppm for Zidovudine and 0.05 ppmto 1.50 ppm for lamivudine. The mean recoveries were 101.24and 97.63% for Zidovudine and Lamivudine, respectively.
Downloads
References
2. L.A., Burke and K.M., Marks (2017), “Drugs to Treat Viral Hepatitis”, Infect. Dis. (Auckl), 1327-1332.
3. D.W., Kimberlin (2018), “Antiviral Agents in: Princ. Pract. Pediatr. Infect. Dis.”, 1551-1567.
4. V.J., Rao; K, Mukkanti; R, Shankar; N.A., Vekariya and A., Islam (2019), “A facile. Detritylation Method for Zidovudine, an Anti-Retroviral DRUG” (6), 15–19.
5. R., Sperling (1998), “Zidovudine” Infect. Dis. Obstet. Gynecol. (6 ), 197–203.
6. S.G., Sarafianos; B., Marchand; K., Das; D., Himmel; M.A., Parniak; S.H., Hughes and E., Arnold (2009), “Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition”, J. Mol. Biol., 385.
7. L.H., Wang; G.E., Chittick and J.A., McDowell (1999), “Single-Dose Pharmacokinetics and Safety of Abacavir (1592U89), Zidovudine and Lamivudine Administered Alone and In Combination In Adults With Human Immunodeficiency Virus Infection”, Antimicrob. Agents Chemother. (43) 1708–15.
8. P.L., Anderson and J.E., Rower (2010), “Zidovudine and Lamivudine for HIV Infection”, Clin. Med. Rev. Ther.,2 .
9. N., Batrawi; H., Naseef and F., Al-Rimawi (2017), “Development and Validation of a Stability-Indicating HPLC Method for the Simultaneous Determination of Florfenicol and Flunixin Meglumine Combination in an Injectable Solution”, J. Anal. Methods Chem., 1–7.
10. B., Shah; S., Jain; K., Prajapati and N., Mansuri (2012), “Stability Indicating HPLC Method Development: A Review, IJPSR, (3), 2978–2988.
11. K.R., Naidu; U.N., Kale and M.S., Shingare (2005), “Stability Indicating RP-HPLC Method for Simultaneous Determination of Amlodipine and Benazepril Hydrochloride from Their Combination Drug Product”, J. Pharm. Biomed. Anal., (39), 147–155.
12. M., Pankhaniya; P., Patel and J.S., Shah (2013), “Stability-indicating HPLC Method for Simultaneous Determination of Montelukast and Fexofenadine Hydrochloride”, Indian J. Pharm. Sci., (75) 284–90.
13. M.R., Sohrabi and M., Tayefeh Zarkesh (2014), “Spectra Resolution for Simultaneous Spectrophotometric Determination of Lamivudine and Zidovudine Components In Pharmaceutical Formulation of Human Immunodeficiency Virus Drug Based on Using Continuous Wavelet Transform and Derivative Transform Techniques”, Talanta, 122 223–228.
Published
How to Cite
Issue
Section
Copyright (c) 2021 Tropical Journal of Pharmaceutical and Life Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
